| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |